
“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
Australia and China work together to deport officials suspected of corruption
For Norway, Oil at $50 Is Worse Than the Global Financial Crisis
Bitcoin developer: Bitcoin Is Not Broken
Mongolia at a crossroad as boom brings challenges
Supreme Court Upholds Maryland Law, Says Police May Take DNA Samples From Arrestees
Federal Election Commission rules requested on Bitcoin campaign donations
Thanks shallot! Indian police foil onion heist
Ca. Democrats want businesses to give half their tax-cut savings to state
Puerto Rico Budget Won’t Include Borrowing, Official Says
What telephone metadata can tell the authorities about you
Saudi Arabia Just Got Turned Into an ETF
Philly narcs face lawsuit by victim of drug raid on auto shop
French crackdown on tax cheats 'to accelerate'
China downgrades U.S. credit rating, accuses of 'holding world hostage'
Man Cavity-Searched After Rolling Stop At Wal-Mart